With Creatio's powerful low-code/no-code tools, both business and IT teams can automate operational and CRM workflows
BOSTON, Oct. 1, 2021 /PRNewswire-PRWeb/ — Creatio, a global software company that provides a leading no-code/low-code platform for process management and CRM, today announced it has been recognized in the September 2021 Gartner Magic Quadrant for Enterprise Low-Code Application Platforms (1).
The report evaluates 12 LCAP vendors, out of the hundreds that market their products as LCAPs, based on their Ability to Execute and Completeness of Vision. According to Gartner®, "Organizations are increasingly adopting LCAPs to enable fusion team development with IT and business to quickly deliver new solutions and modernize business capabilities." In their research they predict that "By 2025, 70% of new applications developed by enterprises will use low-code or no-code technologies, up from less than 25% in 2020."
Creatio believes this recognition is thanks to enterprise-ready flexible low-code capabilities that empower businesses from various industries to automate workflows faster than ever. With Creatio's powerful low-code/no-code tools both business and IT teams can automate operational and CRM workflows of any complexity and gain the freedom to own their automation.
"Low-code and no-code application development has become a real game-changer for many organizations worldwide. We are happy to see that the market matures, and we are inspired by how our customers leverage Creatio low-code platform to automate enterprise-grade workflows across thousands of use cases without touching the code," said Katherine Kostereva, CEO and Founder of Creatio. "It's an honor for us to be recognized by Gartner in their 2021 Magic Quadrant for Enterprise Low Code Application Platforms," she added.
Try Studio Creatio for free >>
(1) Gartner, Magic Quadrant for Enterprise Low-Code Application Platforms, Jason Wong, Kimihiko Iijima, Adrian Leow, Akash Jain, Paul Vincent, 20 September 2021. GARTNER and MAGIC QUADRANT are a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission
Disclaimer: Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Creatio
Creatio is a global software company providing a leading no-code/low-code platform for process management and CRM.
The company has been highly recognized as a market leader by key industry analysts. Its intelligent products accelerate sales, marketing, service and operations for mid-size and large enterprises. Together with hundreds of partners Creatio operates in 110 countries worldwide.
For more information, please visit http://www.creatio.com

Media Contact
Peter Moran, Indicate Media, (347) 880-2895, peter@indicatemedia.com
SOURCE Creatio
Every retail investor wants to ensure a solid portfolio return. The only question is, how? The stock market produces a vast mine of data, that by its nature forms a barrier to access. Some investors take a path of low resistance, and follow one or more market legends. These legends are the giants of the investing world, people like Steven Cohen. The billionaire trader behind Point72 Asset Management has shown that he can survive the vicissitudes of Wall Street. After recovering from Federal inve
Shares of Longeveron (NASDAQ: LGVN) were skyrocketing 72.9% as of 11:51 a.m. ET on Wednesday after more than doubling earlier in the day. An epic short squeeze appears to be underway. Longeveron announced on Nov. 18 that the U.S. Food and Drug Administration (FDA) granted a Rare Pediatric Disease designation to experimental drug Lomecel-B in treating a rare congenital heart defect.
The economist and adviser at Allianz SE says high inflation is here to stay.
Cannabis companies often need to raise money through new share offerings in order to help fund their future growth plans. Investors would probably be happy with a company that simply doesn't issue new shares on an ongoing basis. The idea of a pot producer announcing share repurchases is almost unheard of.
After working together for a time to produce an electric vehicle (EV) in alliance, Ford Motor Company (NYSE: F) and Rivian Automotive (NASDAQ: RIVN) canceled their plans publicly on Friday, Nov. 19. Ford's CEO Jim Farley said Ford is now confident it can design and manufacture EVs on its own. The market reacted by bidding Ford's stock down slightly, while Rivian's shares jumped more than 4% before the close of Friday trading.
In this industry analysis article, we will take a look at the 15 most valuable data companies in the world. You can skip our detailed analysis of these companies, and go directly to the 5 Most Valuable Data Companies in the World. The rapid advance of modern-day computing has created industries that many would have […]
Yahoo Finance Live's Brian Sozzi and Julie Hyman look at Autodesk's shares plunge after weakly beating earning estimates and Faraday Future's dip during a securities claims investigation.
The market's moving higher this year, but three blue chips happen to be laggards. They're cheaper than you think.
Get in on the ground floor of a brand new industry like the metaverse — an iteration of the internet that creates interconnected virtual worlds. Facebook's parent company, Meta Platforms, has reignited interest in metaverse development after announcing plans to commit $10 billion to build what it calls the successor to the mobile internet.
Bear markets can be nerve-wracking, but lower stock prices and valuations also set patient investors up for wealth-building gains. Costco Wholesale might have the most resilient business of all. Comparable sales remained strong during the pandemic, and the current inflationary environment seems to be sending more people in search of value, which is good news for Costco.
For its second quarter ended October 10, 2021, Alimentation Couche- Tard Inc. ("Couche-Tard" or the "Corporation") (TSX: ATD.A) (TSX: ATD.B) announces net earnings of $694.8 million, representing $0.65 per share on a diluted basis. The results for the second quarter of fiscal 2022 were affected by a pre-tax net foreign exchange gain of $4.9 million, as well as pre-tax acquisition costs of $1.8 million. The results for the comparable quarter of fiscal 2021 were affected by a pre-tax gain on dispo
Autodesk beat earnings, but just barely — and when a stock is priced for perfection, that's not good enough.
Teladoc Health (NYSE: TDOC), to many investors the top stock in the mushrooming telehealth segment, looked a bit sickly on Tuesday. The latest in a series of analyst price target cuts was the primary reason for the slide. Following similar adjustments from several of his peers in the stock forecasting realm, Canaccord Genuity analyst Richard Close has chopped his price target for Teladoc.
ARK Invest founder, CEO, and primary stock picker Cathie Wood has seen many of last year's big winners prove mortal this year, but she's not retreating. Roku (NASDAQ: ROKU), Zoom Video Communications (NASDAQ: ZM), and DraftKings (NASDAQ: DKNG) are three of her fund holdings, down 54%, 58%, and 53% respectively from their all-time highs. ARK Invest added to all three positions on Tuesday.
In this article, we discuss the 11 best pipeline and MLP stocks to buy. You can skip our detailed analysis of the industry and go directly to read the 5 Best Pipeline and MLP Stocks to Buy. MLPs mainly operate in the energy industry, especially in pipeline construction. In the initial months of the pandemic, […]
The stock market has seen some volatility pop back up after a strong rally throughout much of October and early November, and after moving to record levels, market benchmarks have started to pull back. High-growth tech stocks have taken a lot of damage over the past couple of weeks, and investors have been responding to earnings releases with a lot of nervousness about whether past rates of growth will continue. On Wednesday morning, two more tech stocks fell sharply following their latest financial reports.
There may be a second wave of COVID-19 vaccines coming. With the hopes of widespread approval of each company's SARS-CoV-2 vaccine, Novavax (NASDAQ: NVAX) is already up nearly 90% year to date while Ocugen (NASDAQ: OCGN) is up over 300% in the same time frame. Patrick Bafuma: To begin, let's take a look at Novavax.
The cryptocurrency fell almost 40% from its value in a week, but good news may be coming that could buoy it again.
Yahoo Finance Live's Brian Sozzi and Julie Hyman break down how Nordstrom stock is dropping after falling short on earnings amid supply chain issues.
Shares of Alibaba Group Holding Ltd. bounced Wednesday, to put them on track to snap the worst five-day performance in their public history, as Susquehanna analyst Shyam Patil slashed his price target but continued to push his "positive" view on the China-based e-commerce giant.


Leave a Reply